日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanobody-enhanced T cell cancer immunotherapy: Advancing precision medicine

纳米抗体增强型T细胞癌症免疫疗法:推进精准医疗

Boisgard, Remy; Prothon, Juliette; Torrielli, Celia; Chames, Patrick; Kerfelec, Brigitte

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis.

AZD1163 的临床前表征,AZD1163 是一种用于治疗类风湿性关节炎的首创抗 PAD2/4 双特异性抗体。

Sims Gary P, Scaletta Lacie, Andrews John, Sims Dorothy A, Strain Martin, Sigurdardottir Anna, Kuriakose Teneema, England Elizabeth, Rajasinghe Lichchavi, Jiang Fanyi, Xiong Ximing, Neal Frances, Vinall Lisa, Newton Philip, Boger Elin, Kim Chong, Dahlbäck Helena, Prothon Susanne, Leander Jacob, Darrah Erika, Collins Mia, Douglas Garry, White Nicholas, Day Katie, Vousden Katherine A, Huntington Catherine E, Close David

A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055

一项评估豪猪蛋白酶抑制剂 AZD5055 的安全性、耐受性和药代动力学的 1 期研究

Zhou, Xiao-Hong; Prothon, Susanne; L, Engin; Ferrari, Nicola; Hezaveh, Kebria; Liu, Zhi; Nemes, Szilard; Almquist, Joachim; Williams, Michael L; Sobande, Olami; Gottfridsson, Christer; Gochuico, Bernadette R; Platt, Adam; Brohawn, Zach; Belvisi, Maria G; Goldwater, Ronald; Hornberg, Ellinor; Owen, Caroline A

AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety study

AZD9567 与泼尼松龙治疗活动性类风湿关节炎患者的疗效比较:一项 IIa 期随机、双盲、疗效和安全性研究

van Laar, Jacob M; Lei, Alejhandra; Safy-Khan, Mary; Almquist, Joachim; Belfield, Graham; Edman, Karl; Öberg, Lisa; Angermann, Bastian R; Dillmann, Inken; Berntsson, Pia; Etal, Damla; Dainty, Ian; Astbury, Carol; Belvisi, Maria G; Nemes, Szilárd; Platt, Adam; Prothon, Susanne; Samuelsson, Sara; Svanberg, Petter; Keen, Christina

Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy Volunteers

健康志愿者吸入选择性糖皮质激素受体调节剂Velsecorat (AZD7594)的安全性、药代动力学和药效学研究

Prothon, Susanne; Aurivillius, Magnus; Tehler, Ulrika; Eriksson, Ulf G; Aggarwal, Ajay; Chen, Yingxue

Oat Polar Lipids Improve Cardiometabolic-Related Markers after Breakfast and a Subsequent Standardized Lunch: A Randomized Crossover Study in Healthy Young Adults

燕麦极性脂质改善早餐后及随后标准化午餐后的心血管代谢相关指标:一项针对健康年轻成人的随机交叉研究

Hossain, Mohammad Mukul; Tovar, Juscelino; Cloetens, Lieselotte; Florido, Maria T Soria; Petersson, Karin; Prothon, Frederic; Nilsson, Anne

Estimation of Equipotent Doses for Anti-Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor Modulator

泼尼松龙和口服选择性非甾体糖皮质激素受体调节剂AZD9567抗炎作用等效剂量的估算

Almquist, Joachim; Sadiq, Muhammad Waqas; Eriksson, Ulf G; Hegelund Myrbäck, Tove; Prothon, Susanne; Leander, Jacob

Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers

选择性糖皮质激素受体调节剂AZD7594在健康日本志愿者吸入后的安全性、药代动力学和药效学研究

Prothon, Susanne; Wählby Hamrén, Ulrika; Tehler, Ulrika; Yoon, Esther; Forsman, Henrik; Arfvidsson, Cecilia; Aggarwal, Ajay; Chen, Yingxue